Advertisement
Screener

PRECISION OPTICS CORPORATION, INC. (POCI) Borrowing debt

PRECISION OPTICS CORPORATION, INC. (POCI) Borrowing debt

  • Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-03-31..
  • Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-03-31..
  • Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-03-31..

Borrowing debt

Overview →

Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Total debt · latest quarter (USD)(m)Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-03-31.

Calculation unavailable: missing inputs remain (m).

Net cash · latest quarter(m)Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-03-31.

Calculation unavailable: missing inputs remain (m).

Debt / assets · latest quarter(m)Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-03-31.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Borrowing debt due within one year577.90K USDLong-term Debt, Current Maturities
Borrowing debt due after one year855.78K USDLong-term Debt, Excluding Current Maturities
Commercial paper(m)
Cash and current securities(m)Cash and Cash Equivalents, at Carrying Value
Borrowing debt(m)Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities
Total assets33.69M USDAssets

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingTotal debtNet cash / debtBorrowing debt due within one year (USD)Borrowing debt due after one year (USD)Commercial paper (USD)Cash and current securities (USD)Total assets (USD)Debt / assets
2026-03-31(m)(m)$577.90K$855.78K(m)(m)$33.69M(m)
2025-12-31(m)(m)$577.90K$1.00M(m)(m)$22.90M(m)
2025-09-30(m)(m)$577.90K$1.14M(m)(m)$22.38M(m)
2025-06-30(m)(m)$577.90K$1.29M(m)(m)$19.79M(m)
2025-03-31(m)(m)$576.40K$1.44M(m)(m)$19.62M(m)
2024-12-31(m)(m)$427.76K$1.61M(m)(m)$17.51M(m)
2024-09-30(m)(m)$285.90K$1.75M(m)(m)$17.24M(m)
2024-06-30(m)(m)$276.93K$1.90M(m)(m)$16.91M(m)
2024-03-31(m)(m)$513.26K$1.79M(m)(m)$18.27M(m)
2023-12-31(m)(m)$513.26K$1.92M(m)(m)$17.70M(m)
2023-09-30(m)(m)$513.26K$2.05M(m)(m)$19.07M(m)
2023-06-30(m)(m)$513.26K$2.18M(m)(m)$19.74M(m)
2023-03-31(m)(m)$371.43K$1.68M(m)(m)$18.19M(m)
2022-12-31(m)(m)$371.43K$1.77M(m)(m)$17.47M(m)
2022-09-30(m)(m)$371.43K$1.87M(m)(m)$17.17M(m)
2022-06-30(m)(m)$367.71K$1.96M(m)(m)$16.70M(m)
2022-03-31(m)(m)$367.71K$2.05M(m)(m)$17.27M(m)
2021-12-31(m)(m)$367.71K$2.15M(m)(m)$16.89M(m)
2021-06-30(m)(m)$0.00$0.00(m)(m)$6.26M(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Outset Medical, Inc. (OM)United States$0.059B-1.09
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
Streamex Corp. (STEX)United States$0.089B-0.19
IRIDEX CORP (IRIX)United States$0.011B
Nexalin Technology, Inc. (NXL)United States$0.094B
ENDRA Life Sciences Inc. (NDRA)United States$0.009B
Neuraxis, INC (NRXS)United States$0.097B
Nuwellis, Inc. (NUWE)United States$0.003B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B